Current Studies in Surgical Shock Shock, be it the result of hypovolimia, heart failure, or sepsis, remains a challenging research topic stimulating the production of some 2000 papers a year in the medical literature. This interest stems not so much from the clinical problems presented by shocked patientsthe condition is now usually recognized earlier and more successfully treated than ever beforebut because shock produces in gross degree the pathophysiological and metabolic changes that occur every time a patient is injured or undergoes surgical operation. Thus, in its experimental form, hamorrhagic shock provides a readily reproducible method for studying the responses to a standardized degree of trauma.
The FundamentalLesion in Shock: The Changing Theories When a patient is subjected to extensive blood, plasma, or tissue fluid loss he becomes pale, sweaty, confused and oliguric, develops a tachycardia and eventually becomes hypotensive; i.e. he exhibits the classical shock syndrome. Provided adequate intravenous fluid replacement is rapidly given the condition will reverse and the patient will be none the worse. If, however, the hypovolkmic shock state persists for a long period, damage to fundamental metabolic and physiological processes occurs. In such cases, although correction of the hypovolkmia will reverse the cardiovascular effects and render the patient normotensive, some already established defects will persist and others will develop. Ileus, renal failure, chest infections and coagulopathies may arise individually or in combination and if severe enough will lead to death.
Since the turn of the century, when interest in the problem of shock first began, numerous explanations have been put forward for the progressive deterioration that results from sustained hypovolemic hypotension, notably vasomotor collapse (Crile 1899), circulating toxic factors (Bayliss & Cannon 1919) , disseminated intravascular coagulation (Hardaway & McKay 1959) and myocardial failure (Guyton & Crowell 1961). In the 1960s the 'tissue underperfusiontissue hypoxia' theory, on which current therapeutic regimes are based, came to the fore. This was based on the reasonable assumption that in hypovolamic shock the reduced cardiac output in combination with catecholamine-induced compensatory vasoconstriction results in underperfusion of the tissues and cellular hypoxia. The metabolic acidosis that invariably accompanies shock states was attributed, on similar reasoning, to the tissue hypoxia causing conversion of aerobic carbohydrate metabolism to anaerobic metabolism with a consequent accumulation of lactic acid. The logical aim in treating shock was thus seen as the restoration of flow by adequate volume expansion and if necessary, the use of vasodilator therapy.
Although this approach to treatment remains unchallenged recent studies have cast doubt on the explanation of shock on which it is based. In our studies (Halmagyi et al. 1967 , Irving 1968 we confirmed that both sustained hypotension due to haemorrhage, and the infusion into intact animals of adrenaline in amounts sufficient to raise the blood levels to those produced endogenously by hiemorrhage, led to nearly identical states of metabolic acidosis and irreversible shock. Such a situation, if the vasoconstrictiontissue underperfusiontissue hypoxia reasoning is correct, should have been prevented or at least mitigated by the use of an adrenergic blocking agent such as phenoxybenzamine, which blocks the a (vasoconstrictor) activity of adrenaline.
In our studies a-adrenergic blockade, although effectively blocking pressor activity in both adrenaline infusion and heemorrhage, did not prevent either the development of metabolic acidosis or the onset of irreversible shock. On the other hand, animals in which both the a-and ,B-adrenergic receptors had been blocked prior to the infusion of adrenaline or the onset of hemorrhage developed neither a metabolic acidosis nor a state of irreversible shock, despite the fact that vasoconstrictor activity was once again evident. These experiments suggested that development of irreversible shock and metabolic acidosis depended not on changes in blood flow to and oxygenation of the tissue, but on changes in cellular metabolism mediated through the aand P-adrenergic receptors. Confirmation came from the studies of Makin (1971) , who demonstrated that in hemorrhagic shock the production of lactic acid was independent of the adequacy of tissue perfusion. More recently Wright et al. Section of Surgery (1971) have shown that in septic shock the failure of oxygen uptake by the tissues is the result, not of tissue underperfusion, but of failure in cellular metabolism.
Research in the 1970s seems likely to centre on further investigation of the defects in cellular metabolism that occur in shock and of the factors which cause them. The circulatory changes will no longer be seen as the prime cause of the cellular failure in shock, but as the most prominent clinical feature of the shock state, observation of which will give an indication of the severity of the condition as a whole and of the success of its treatment.
Therapeutic Implications-ofRecent Studies Correction of hypovolemia: With emphasis on the therapeutic importance of restoration of flow in shocked patients the need to give adequate quantities of replacement fluid and the avoidance of vasopressors are now well established. The assessment of a shocked patient's volume requirements has been controversial for some time and only recently has some measure of agreenfent been reached.
Initially, when assessing the fluid requirements of a shocked patient, it appeared logical to predict his blood volume from height and weight, measure his actual volume, and make up the deficit. Although measurement of blood volume using dye solution has long been feasible, the investigation only became a practicality with the introduction of isotope dilution techniques in which the plasma volume was calculated using 125I-labelled human albumin, the total volume being deduced from the venous hmmatocrit. Even more accurate estimations could be obtained if in addition the red cells were labelled with 51Cr.
Despite initial enthusiasm the method was gradually abandoned for several reasons. First there was evidence that isotope mixing in the circulation was not uniform in shock states, and also that one could not assume that the ratio of whole body h;ematocrit to venous hematocrit, the so-called F cells ratio vital for calculating blood volume, would retain in shock states its normal constant value of 0.91. Recently Walters et al. (1969) have shown that standard methods for predicting the blood volume from height and weight give errors involving over 500 ml in 40% of cases, and of over 700 ml in 20 %.
The most significant factor in the abandonment of blood'volume measurements in the therapy of shock was,' however, the realization that the results obtained bore little or no relationship to the needs of the patient. It was soon appreciated that in some shocked patients restoration of normal blood volume did not reverse the state of shock. Initially this situation was termed normovolmnic shock, but it has been virtually aban-doned as a diagnosis'since it was realized that the administration of further fluid in such patients, often in large quantities, could reverse the state of shock.
Some other index of the adequacy of volume replacement was therefore needed. For routine assessment of the volume requirements of a shocked patient measurement of the pressure in the right atrium, the so-called 'central venous pressure', is, despite occasional limitations, now generally accepted as the most useful index.
The recent introduction of thermodilution methods of measuring cardiac output may make facilities for this measurement more easily available at the bedside of the shocked patient (Branthwaite & Bradley 1968 ). The concept of benign hypotension: Associated with the realization of the importance of restoring flow and maintaining an adequate venous pressure in the treatment of shock has been an appreciation of the relative unimportance of the arterial pressure, especially in cases associated with sepsis. Patients after recovery from an episode of septicoemia may have a low arterial pressure with a systolic reading around 70-80 mmHg. Yet, if they are warm and well perfused, have full peripheral veins and a good pulse volume, and continue to pass adequate amounts of urine, they can be said to be in a state of 'benign hypotension' (Walters 1969) . In these cases no attempt should be made to raise the arterial pressure by pharmacological means, i.e. by using vasopressors or steroids; with adequate fluid administration the pressure will spontaneously revert to normal over 2-3 days. Corticosteroids: The widespread use of corticosteroids in shock states followed the suggestion made by workers in the United States that their administration improves the survival in both clinical and experimental shock (Lillehei et al. 1964 ). The practice is now well established and few omit to use them in the treatment of shock, especially that associated with sepsis. The evidence for their value is, however, largely subjective and difficult to assess because of the coincident administration of other treatment.
Careful clinical studies by Shoemaker (1970) failed to demonstrate any significant effect of steroids when used in the treatment of shock. Such findings support the opinions of McGowan (1969) , and a recent Lancet editorial (Lancet 1971) in which the evidence for their value was considered unimpressive. A recent paper has, however, suggested that the reason for the lack of effect in some cases is that the wrong steroid has been administered, and that beneficial results will only be obtained with methylprednisolone sodium succinate (Wilson 1972) . Until this claim is investigated the case against the value of steroids in the treatment of shock cannot be concluded. 54 Coagulation Changes in Shock I shall now describe some of the studies currently being undertaken at St Bartholomew's.
It is well recognized that in shock states and after injury there is an increase in the coagulability of the blood. Hardaway (1962) has demonstrated that when shock, both experimental and clinical, is prolonged, intravascular coagulation occurs throughout the microvasculature. This can lead to the consumption of clotting factors resulting in a hypocoagulable statethe so-called 'consumption coagulopathy' (Lasch 1969) .
The exact reasons for the initiation of the hypercoagulability are not known and many factors have been suggested. There is evidence that it may be associated with the high adrenaline levels known to occur in shock states.
In 1966 Ingram & Vaughan Jones showed that infusion of adrenaline into man causes a rise in clotting factor VIII levels. More recently Whitaker et al. (1969) have shown that infusion of adrenaline into rabbits will produce disseminated intravascular coagulation. With this knowledge we are at present investigating the association between adrenaline production and the development of hypercoagulability in response to surgery and experimental shock.
In a pilot series of experiments we studied the coagulation mechanisms of sheep bled into hemorrhagic shock and the influence upon these mechanisms of adrenergic blockade with a-and ,B-blockers used singly and in combination (Irving & Hawkey 1972) . Four groups of 3 animals were used. In the first group, of 3 nonmedicated animals, we were, as expected, able to show activation of the coagulation mechanisms with an increase in clotting factor production and evidence of platelet consumption. Similar findings were observed in animals under a-adrenergic blockade with phenoxybenzamine. On the other hand, fl-adrenergic blockade with propranolol prevented activation of the coagulation mechanisms, a similar response being observed in the animals under combined a-and ,B-adrenergic blockade. Adrenergic stimulation therefore seems to play a significant role in the activation of coagulation in shock states, and is mediated through the ,B-receptor.
These observations are being further pursued by the study of the coagulation and fibrinolytic responses in animals subjected to adrenaline infusion.
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The Cancer Cell It is impossible to cover all aspects of the nature of the cancer cell in a short presentation, and I will therefore concentrate on some which I believe of particular interest at present and which are being studied in our laboratory.
Since one cancer cell when it divides gives rise to further cancer cells, the cell must have been changed in such a way that the newly acquired characteristics are stabilized. There are two possible explanations. First, there may be a change in the regulation of the existing genetic material more akin to differentiation than to somatic mutation; several facts support this hypothesis. In particular, the appearance on the cell surface of new antigens, which are apparently identical with antigens previously expressed during embryonic development, suggests an alteration in the regulation of function of the genetic material, for example, the carcinoembryonic antigen which has been found on the cells of carcinoma of the colon (Gold 1971) , and, more recently, on a number of other malignant neoplasms (Lo Gerfo et al. 1971) . Secondly, there are a number of reported instances of reversion of malignant cells to normal cells in tissue culture systems (Hitotsumachi et al. 1972) , which strongly suggests that regulation of function is of great importance. It is possible, however, that these cases of reversion which occur in a laboratory model system do not reflect the behaviour of malignant cells in vivo. Lastly, some cancer cells do not have any obvious alterations of the chromosomes. This could suggest that no
